Cantitate/Preț
Produs
Total produse
Vezi coșul
Myeloma Bone Disease de G. David Roodman

Myeloma Bone Disease: Current Clinical Oncology

Editat de G. David Roodman
en Limba Engleză Paperback – iul 2012
This book presents the forefront in the science and clinical management of myeloma bone disease. Coverage begins with sections on clinical presentation, imaging, and biochemical markers and goes on to discuss radiation, surgical, and medical therapies.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 151681 lei  6-8 săpt.
  Humana Press Inc. – iul 2012 151681 lei  6-8 săpt.
Hardback (1) 134194 lei  6-8 săpt.
  Humana Press Inc. – 4 mai 2010 134194 lei  6-8 săpt.

Din seria Current Clinical Oncology

  • 5% Principles and Practice of Cancer Infectious Diseases
    Preț: 161138 lei
  • 5% Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development
    Preț: 68838 lei
  • 5% Hepatocellular Carcinoma: Diagnosis and Treatment
    Preț: 110266 lei
  • 5% Rectal Cancer: International Perspectives on Multimodality Management
    Preț: 74132 lei
  • 5% Lung Cancer:: Prevention, Management, and Emerging Therapies
    Preț: 171179 lei
  • 5% Current Controversies in Bone Marrow Transplantation
    Preț: 135893 lei
  • 5% Patient Surveillance After Cancer Treatment
    Preț: 134248 lei
  • 5% Intraoperative Irradiation: Techniques and Results
    Preț: 135877 lei
  • 5% From Local Invasion to Metastatic Cancer: Involvement of Distant Sites Through the Lymphovascular System
    Preț: 134579 lei
  • 5% Primary Central Nervous System Tumors: Pathogenesis and Therapy
    Preț: 153346 lei
  • 5% Cancer in the Spine: Comprehensive Care
    Preț: 135912 lei
  • 5% Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management
    Preț: 74202 lei
  • 5% Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done
    Preț: 105666 lei
  • 5% Colorectal Cancer: Multimodality Management
    Preț: 187712 lei
  • 5% Biology and Management of Multiple Myeloma
    Preț: 105127 lei
  • 5% Cancer of the Lung: From Molecular Biology to Treatment Guidelines
    Preț: 105077 lei
  • 5% Regional Chemotherapy: Clinical Research and Practice
    Preț: 74880 lei
  • 5% High-Grade Gliomas: Diagnosis and Treatment
    Preț: 153626 lei
  • 5% Neuroendocrine Tumors
    Preț: 73976 lei
  • 5% Treatment of Acute Leukemias: New Directions for Clinical Research
    Preț: 173296 lei
  • 5% Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies
    Preț: 106324 lei
  • 5% Breast Cancer: A Guide to Detection and Multidisciplinary Therapy
    Preț: 105873 lei
  • 5% Targeted Cancer Therapy
    Preț: 70641 lei
  • 5% Intraperitoneal Cancer Therapy
    Preț: 104277 lei
  • 5% Melanoma: Biologically Targeted Therapeutics
    Preț: 35558 lei
  • 5% Uterine Cancer: Screening, Diagnosis, and Treatment
    Preț: 151311 lei
  • 5% Targeted Therapeutics in Melanoma
    Preț: 74378 lei
  • 5% Molecular Pathology of Gynecologic Cancer
    Preț: 105230 lei
  • 5% Breast Cancer in the Post-Genomic Era
    Preț: 104591 lei
  • 5% Integrative Oncology: Incorporating Complementary Medicine into Conventional Cancer Care
    Preț: 73646 lei

Preț: 151681 lei

Preț vechi: 159664 lei
-5% Nou

Puncte Express: 2275
Preț estimativ în valută:
29029€ • 30815$ • 24188£

Carte tipărită la comandă

Livrare economică 26 decembrie 24 - 09 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781617796883
ISBN-10: 1617796883
Pagini: 264
Ilustrații: X, 252 p. 75 illus., 43 illus. in color.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.37 kg
Ediția:2010
Editura: Humana Press Inc.
Colecția Humana
Seria Current Clinical Oncology

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

Clinical Presentation of Myeloma Bone Disease.- Imaging of Multiple Myeloma, Solitary Plasmacytoma, MGUS, and Other Plasma Cell Dyscrasias.- Biochemical Markers of Bone Remodeling in Multiple Myeloma.- Radiation Therapy in Multiple Myeloma.- Surgical Management of Bone Disease.- Bisphosphonates in the Treatment of Myeloma Bone Disease.- Osteonecrosis of the Jaw.- Murine Models of Myeloma Bone Disease: The Importance of Choice.- RANK Ligand Is a Therapeutic Target in Multiple Myeloma.- Osteoclast Activation in Multiple Myeloma.- Potential Role of IMiDs and Other Agents as Therapy for Myeloma Bone Disease.- Proteasome Inhibitors and the Wnt Signaling Pathway in Myeloma Bone Disease.- Mechanisms Involved in Osteoblast Suppression in Multiple Myeloma.

Recenzii

From the reviews:
“This is a highly specialized book dealing with myeloma bone disease. … The book, authoritative as it is, is likely to be of interest to … physicians and scientists with a specific interest in myeloma. … No other book has dealt with the subject of myeloma bone disease in as much depth and, therefore, this one is unique.” (Seema Singhal, Doody’s Review Service, February, 2011)

Textul de pe ultima copertă

This state-of-the-art book presents the forefront in the science and clinical management of myeloma bone disease.  Assembling the work of the world's premier thought leaders, this book begins with sections on clinical presentation, imaging, and biochemical markers and then goes on to discuss radiation, surgical, and medical therapies.  Specific chapters are devoted to bisphosphonates and novel therapeutic agents, such as RANKL inhibitors, Wnt signaling inhibitors, and IMiDs.  The mechanisms of osteoclast activation and osteoblast suppression in multiple myeloma are also explored.
Myeloma Bone Disease is a valuable resource for medical, surgical, and radiation oncologists and cancer researchers.

Caracteristici

Presents state-of-the-art knowledge gleaned from revolutionary clinical trials Explores exciting advances in novel therapeutics Covers medical, surgical, and radiation oncology perspectives Discusses new imaging techniques for myeloma bone disease Discusses the use of new bone markers for monitoring disease progression Features unique material of interest to both clinicians and researchers Includes supplementary material: sn.pub/extras